Absent T Lymphocytes

Search Trials
Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia
Status:
Active, not recruiting
Last Changed:
May 24, 2022
First Changed:
Jun 29, 2015
Disease(s):
B Acute Lymphoblastic Leukemia
Intervention(s):
Laboratory Biomarker AnalysisPharmacological StudySapanisertib
CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study
Status:
Recruiting
Last Changed:
Jan 6, 2021
First Changed:
Jul 21, 2020
Disease(s):
T Lymphoblastic Leukemia/Lymphoma
Intervention(s):
T cell injection targeting CD7 chimeric antigen receptor
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
Status:
Unknown status
Last Changed:
Jan 6, 2014
First Changed:
Jan 27, 2003
Disease(s):
Leukemia
Intervention(s):
anti-thymocyte globulincyclosporinefludarabine phosphatemelphalanmethylprednisolonemycophenolate mofetilallogeneic bone marrow transplantationperipheral blood stem cell transplantationsyngeneic bone marrow transplantation
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Status:
Active, not recruiting
Last Changed:
Feb 8, 2022
First Changed:
May 31, 2019
Disease(s):
Solid Tumor
Intervention(s):
NeoTCR-P1 adoptive cell therapynivolumabIL-2
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Status:
Unknown status
Last Changed:
Dec 18, 2013
First Changed:
Oct 9, 2008
Disease(s):
Cancer
Intervention(s):
cytomegalovirus IE-1-specific cytotoxic T lymphocytescytomegalovirus pp65-specific cytotoxic T lymphocytestherapeutic allogeneic lymphocytespolymerase chain reactionflow cytometryimmunological diagnostic methodlaboratory biomarker analysis

Connect. Empower. Inspire.